Cellebrite DI (CLBT) Price to Sales (2020 - 2026)

Cellebrite DI has reported Price to Sales for 7 years, with the latest figure at 27.77 in Q2 2026.

• On a quarterly basis, Price to Sales fell 17.9% year-over-year to 27.77 in Q2 2026; TTM through Jun 2026 was 7.08, a 19.28% decrease from a year earlier, with the FY2025 full-year figure at 9.45, down 28.1% from the prior year.
• Price to Sales was 27.77 for Q2 2026 at Cellebrite DI, up from 26.79 in the prior quarter.
• The five-year high for Price to Sales was 48.38 in Q4 2024, with the low at 6.82 in Q3 2022.
• Average Price to Sales over 5 years is 24.81, with a median of 25.51 recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Price to Sales sank 61.09% in 2022, then soared 159.49% in 2023.
• Over 5 years, Price to Sales stood at 11.47 in 2022, then soared by 66.67% to 19.11 in 2023, then soared by 153.1% to 48.38 in 2024, then dropped by 27.83% to 34.91 in 2025, then fell by 20.45% to 27.77 in 2026.
• The last three Price to Sales figures came in at 27.77 (Q2 2026), 26.79 (Q1 2026), and 34.91 (Q4 2025), per Business Quant data.